Guldman S$chs pyta w raporcie czy wyleczenie pacjentów to dobry model biznesowy?
Goldman Sachs warns sales from the most successful disease treatments are difficult to maintain. gene therapy treatment: cures could be bad for business in the long run.
z- 158
- #
- #
- #